Cellectar Biosciences, Inc. Long-Term Debt, Maturity, Year Two
Cellectar Biosciences, Inc. (CLRB) had Long-Term Debt, Maturity, Year Two of $86.63 thousand as of 2015-12-31, per its 10-K/A filed 2016-10-20.
Discontinued › Notes › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2016-10-20
- 2015-12-31: Long-Term Debt, Maturity, Year Two $86.63K.
- 2014-12-31: Long-Term Debt, Maturity, Year Two $243.59K.
- 2013-12-31: Long-Term Debt, Maturity, Year Two $119.96K.
- 2012-12-31: Long-Term Debt, Maturity, Year Two $0.00.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2015-12-31 | $86.63K 10-K/A · filed 2016-10-20 |
| 2014-12-31 | $243.59K 10-K · filed 2015-05-20 |
| 2013-12-31 | $119.96K 10-K · filed 2014-03-19 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |